The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 DexCom Inc.  (DXCM) Trade Now »     Rate DXCM  -  Discuss DXCM  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Medical Equipment & Supplies
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
75.0%
Top:
100.0%
Rate DXCM:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

DXCM: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

DexCom Loss Narrows – Analyst Blog
Logo1
38%

DexCom, Inc. (DXCM) reported a net loss of 29 cents per share in the third quarter, 3 cents below the Zacks Consensus Estimate of a net loss of 32 cents and significantly below the year-ago net loss of 53 cents. The significant improvement in financial results was due to higher revenue. 

Revenue came in at $7.3 million, up 278% from the $1.9 million reported in the year-ago period. Total revenue consists of product revenue and development grant revenue. Development grant revenue came in at $2.6 million. 

Product revenue increased 146% to $4.6 million for the third quarter of 2009. On a sequ...
By  StraightStocks   (-6.13%  risk: moderate)  11/13/09 Comment


Create Your Own Diagnostics ETF
Mikerun
73%
With HealthShares closing shop at year-end, including the former Diagnostics fund, investors who are interested in the space can create their own ETF comprised of companies from the ETF Innovators Preventive Medicine and Emerging Diagnostics Indexes. Below is a list of companies which have stocks listed for trading in the U.S. at over $1/share with a market cap of less than $10B, focusing on smaller companies which are more leveraged to diagnostics and represent possible takeover targets for larger players such as Roche (RHHBY), Abbott Labs (ABT), and Johnson & Johnson (JNJ).

However, the sm...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/20/09 Comment


A New Emerging Diagnostics Index
Mikerun
73%


The accompanying table [click to enlarge] includes 39 companies in the ETF Innovators [ETFI] Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic analysis + molecular diagnostic companies such as Affymetrix (AFFX).

AFFX is a sto...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/26/08 Comment


A New Emerging Diagnostics Index
Mikerun
73%


The accompanying table [click to enlarge] includes 39 companies in the ETF Innovators [ETFI] Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic analysis + molecular diagnostic companies such as Affymetrix (AFFX).

AFFX is a sto...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/26/08 Comment


DexCom Shares Warrant Caution
Logo1
38%

DexCom, Inc. (DXCM) reported a second-quarter net loss of $0.48 per share compared with a net loss of $0.40 per share in the comparable period last year. We are pleased with top line product revenue growth and are encouraged by the recently announced contract with Blue Cross of California for limited reimbursement of continuous glucose-monitoring (CGM) to patients in California and across the Anthem Blue Cross network.

<>We remain mindful of the recent approval of Abbott Labs' (ABT) CGM system by the Food and Drug Administration; however, we regard any progress on the reimbursement front towa...
By  StraightStocks   (-6.13%  risk: moderate)  08/12/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
DRYS DryShips Inc.
DELL Dell Inc
BAC Bank of America Corp
WFC Wells Fargo & Company
EBAY eBay Inc
V Visa Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on DXCM

Visit streetinsider.com


Discussion Wall + Add  

Be the first to start a discussion and earn 2 points.



More Resources

Graphic_arrow1 About DexCom Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch